The ongoing partnership between the Data Sciences Institute and AstraZeneca Canada enables a dialogue between one of the country’s leading research-based pharmaceutical companies and emerging talent at one of the world’s leading universities in data science and AI.
Access to emerging data science and AI talent is part of what brought AstraZeneca Canada to DSI as an Industry Partner. Investing in this talent pipeline is part of their strategy to create global impact by using data to transform science and deliver life-changing medicines.
The Data Science and AI Talent Showcase this January was an opportunity for AstraZeneca to hear from DSI scholars trained in data sciences, and AI methods and tools that align the pharmaceutical sector’s needs. The poster session showcased applied research from undergraduate and doctoral students, and postdoctoral fellows from across the U of T and research institute partners who were keen for the opportunity to speak with and gain insight from representatives from AstraZeneca Canada.
The Industry Speaker Series forum on April 27 is the next turn in the dialogue. This interactive afternoon will feature three speakers from AstraZeneca Canada offering insights from different perspectives within the organization: Martin Booth, Head of Analytics & Data Excellence, Devon Prontack, Senior Manager, Data Science & Innovation, and Amyn Sayani, Head of Medical Evidence.
AstraZeneca uses real-world health data to generate insights, address evidence gaps, and navigate challenges in accessing and connecting health data across Canada. Their speakers will share perspectives on medical evidence, synthetic data, and decision making in applied commercial data science. By highlighting elements of their work and challenges that they face, AstraZeneca opens avenues for discussion and collaboration with DSI’s community.
The entire afternoon is designed to enable such collaboration and dialogue. With ample open networking providing opportunities for unstructured dialogue, AstraZeneca will also join Michael Brudno (Chief Data Scientist, University Health Network), Laura Rosella (Professor, Dalla Lana School of Public Health, University of Toronto), Lillian Sung (Chief Clinical Data Scientist, The Hospital for Sick Children) and Mina Tadrous (Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto) for a panel moderated by Lisa Strug, Director of the Data Sciences Institute. Drawn from U of T and affiliated hospital partners, these experts will bring insights on implementation challenges, data access realities, and opportunities for collaboration between industry and the research community.
Lisa Strug, Director, Data Sciences Institute, speaks to the ongoing value of this partnership. “We see this as truly a two-way collaboration. We are thrilled to see the connections that are formed through AstraZeneca’s access to the U of T talent pipeline and the DSI community’s exposure to AstraZeneca’s insights in practice.”
“We’re excited to join the Data Sciences Institute to discuss how industry is using health data to generate real-world evidence and where collaboration can help unlock data science insights for healthcare,” says Martin Booth, Head of Analytics & Data Excellence at AstraZeneca Canada.
The Data Sciences Institute welcomes industry leaders ready to launch their own dialogue with the DSI community. Our Industry Partnership model connects industry leaders with top-tier data science, fostering collaboration through industry engagement and trainee development opportunities. Organizations gain direct access to exceptional students and researchers, strengthening their presence in the next generation of data-driven talent. See our Industry Partnership Model and contact parterships.dsi@utoronto.ca to get started.